Background: Gonadotropins induce follicular development that leads to ovulation and
| INTRODUCTION
Gonadotropin receptors consist of a follicle-stimulating hormone receptor (FSHR) and a luteinizing hormone receptor (LHR), their expression of which is observed in numerous tissues. [1] [2] [3] [4] [5] However, the main target of the ligands of these receptors is the gonads and these ligands and receptor systems play crucial roles in the reproductive function of both men and women. These functions include: steroid genesis in the testis and ovary; follicular development, ovulation, and luteinization in women; and spermatogenesis in men. 6, 7 Physiologically, FSHR can bind solely to FSH, whereas LHR can bind to both luteinizing hormone (LH) and human chorionic gonadotropin (hCG). These receptors are members of the rhodopsin/β2 adrenergic receptor subfamily of seven G-protein-coupled transmembrane receptors. Thyroid-stimulating hormone receptor also belongs to this subfamily. The characteristic structural features of the receptors that belong to this subfamily are seven transmembrane regions and a relatively large extracellular domain. The determination of the cDNA sequences of FSHR and LHR was achieved by Minegishi et al. 8 ,9
| FOLLICLE-STIMULATING HORMONE RECEPTOR EXPRESSION IN THE GRANULOSA CELLS
According to the result of a hormone-binding experiment, FSHR expression was not observed in the primordial follicles. In the secondary follicle, along with the appearance of theca cells, FSHR was noted to exist on the surface of the granulosa cells. 10 The FSHR expression increased as the follicle grew from the preantral to the antral stage and maintained a steady level in the follicle of a 3-12 mm diameter. In the authors' previous study, the mRNA expression of FSHR peaked in the mid-follicular phase and its relative value was twice of that in the luteal phase. 8 In a hypophysectomized rat that lacked FSH secretion, antral follicular formation was disturbed; however, FSHR expression was conserved. In FSHR knock-out mice, antral follicular formation was inhibited. 11 These findings suggest that FSH plays an essential role in antral follicular formation, but that FSHR expression is induced through a mechanism other than FSH stimulation.
| Androgens
Several studies have suggested that androgen plays a major role in FSHR expression. In the study on a Rhesus monkey model, FSHR and androgen receptors were co-expressed in the same follicles. 12 Moreover, in the granulosa cells, the administration of testosterone to the Rhesus monkey induced FSHR mRNA expression and FSHstimulated expression of androgen receptors. 13 These results indicate that, in the granulosa cells, FSHR is induced by androgen in a coordinated way. In a recent report on the primary culture of mouse granulosa cells, androgen induced FSHR expression at the protein level on the cell surface. 14 Additionally, in a study on human ovarian granulosa cells, the expression of both FSHR and androgen receptors were the highest in the small antral follicle and gradually decreased as the follicle grew. 
| Growth differentiation factor-9
For androgen-induced FSHR expression, the involvement of oocytederived growth differentiation factor-9 (GDF9) might be essential as it contributed to follicular growth from the preantral to the antral stage through the induction of androgen production in the theca cells. 16 Additionally, in the study on an in vitro follicular culture system, when GDF9 in the oocyte was knocked down by the microinjection of the anti-sense oligonucleotide of GDF9, FSHR expression in the granulosa cells was suppressed and apoptosis of the granulosa cells was induced. These effects of GDF9 knock-down led to follicular growth arrest. 17 These knock-down effects of GDF9 were rescued by the addition of GDF9 itself or by the addition of an androgen. These results suggest that GDF9 is indispensable for FSHR expression in the granulosa cells and that this phenomenon is achieved via androgen signaling.
Collectively, during the growth from the preantral to the antral follicle, FSHR expression in the granulosa cells is, at least partly, controlled by oocyte-derived GDF9 through androgen synthesis from the theca cells. These are now discussed.
| LUTEINIZING HORMONE RECEPTOR EXPRESSION IN THE GRANULOSA CELLS

| Activin
Activin is a growth factor that belongs to the TGF-β superfamily and is expressed in the ovarian granulosa cells with concurrently expressed activin receptor. In rat granulosa cells, activin has been observed to strongly induce FSHR 22, 23 and CYP19A1 24 expression. It also enhanced LHR expression that was induced by FSH. 25 On the contrary, in the theca cells, activin markedly suppressed androgen production that was induced by insulin-like growth factor (IGF)-1 and LH. 26 Moreover, with the growth of the follicle, activin production from the granulosa cells decreased. Simultaneously, the production of inhibin and follistatin (activin-binding protein) from the granulosa cells increased. 27 In the rat ovarian granulosa cell culture system, the addition of activin to the medium resulted in a drastic increase in FSHR expression. However, when the cells were stimulated with FSH, activin production rapidly decreased. 28 Based on these findings, activin is considered to be secreted mainly from the granulosa cells before FSH installation and could be involved in the maintenance of the gonadotropin receptors. In a recent report involving human samples, the activin concentration in the follicular fluid was increased in follicles with a diameter that was >10 mm. 29 However, FSHR expression decreased in the follicles at this stage. Therefore, the interaction between activin and FSHR expression is unclear after this stage.
| Insulin-like growth factor-1
The IGF system is composed of a ligand, receptor, and binding protein and controls its bioactivity. Insulin also can bind to the IGF receptor and affect the system. In the ovary, IGF-1 expression is identified exclusively within developing and mature follicles. 30 The localization of IGF-1 expression in the follicles corresponded to that of FSHR and aromatase. 31 In human samples, IGF-1 expression was observed only in the antral follicles with a 3-5 mm diameter. On the contrary, its receptor could be found in most of the follicles from the primary to the preovulatory stage. 18 In the rat granulosa cell culture system, the addition of IGF-1 in the medium strongly enhanced LHR expression that was induced by FSH stimulation. [32] [33] [34] In Based on these findings, LHR expression in the granulosa cells that are induced with FSH is enhanced by IGF-1 that is derived from LHstimulated theca cells.
| Estrogen
Estrogen is a steroid hormone and a final product of the hypothalamus-pituitary-ovary axis. Estrogen is produced and secreted by the granulosa cells as a result of FSH stimulation that activates CYP19A1 and converts androgen into estrogen. Estrogen receptors (ERs) are distributed throughout the body and one of the main target organs is the uterus. The granulosa cells also express ERs and estrogen contributes to follicular development in an autocrine/paracrine manner. 36 In the ERβ-knockout mice, the differentiation of the granulosa cells that were induced by FSH stimulation was abolished, aromatase activity was decreased, and LHR expression became insufficient. As a result, ovulation decreased and the expansion of the cumulus cells-oocyte complex (COC) became imperfect. These reactions were not evident in the ERα-knockout mouse. Therefore, differentiation of the granulosa cells, according to follicular development, is thought to be controlled via the ERβ pathway. 37 In the rat granulosa cell culture system, estrogen alone could not induce LHR and did not change FSHR expression, but it did enhance LHR expression that was induced by FSH. In this phenomenon, estrogen did not enhance the transcription of LHR mRNA, but stabilized LHR mRNA.
Mevalonate kinase (Mvk) negatively correlated to this change. Codoped FSH and estrogen inhibited Mvk expression and its negative involvement with LHR. As a result, LHR expression was upregulated.
This interaction of Mvk also was confirmed with the experiment on the overexpression of Mvk that diminished the positive estrogen effect. 38 Mvk also could be involved in the transient downregulation of LHR after an LH surge. 39 
| Interleukin-6
Interleukin-6 (IL-6) is one of the cytokines that control humoral immunity. It was originally identified as a B-cell differentiation factor. 40 In previous reports, it was reported that the rat granulosa cells also can secrete IL-6 41, 42 and that its secretion was increased by FSH stimulation. 43 There were several reports on the effect of IL-6 on follicular development. In one report, the addition of IL-6 into the rat granulosa cell culture medium inhibited LHR expression. 44, 45 In other reports, IL-6 inhibited estradiol and progesterone production that were induced by FSH stimulation in the granulosa cells. 46, 47 On the contrary, in another report, IL-6 expression was increased during COC expansion and the addition of IL-6 to the culture system accelerated the COC expansion. 48 Based on these findings, the authors studied the 
| TRANSIENT DOWNREGULATION OF LUTEINIZING HORMONE RECEPTOR AFTER A LUTEINIZING HORMONE SURGE
As mentioned above, during follicular development from the antral follicle, LHR expression was induced by FSH stimulation. This expression was enhanced further by various local factors that were derived from the granulosa and theca cells in a coordinated way. These changes are crucial for the preparation of a LH surge, which is absolutely necessary for oocyte maturation, ovulation, and transformation of the follicle and luteinization.
Until the LH surge, a constant increase in LHR expression continued. However, immediately after the LH surge, a sharp decrease in LHR mRNA expression in the preovulatory follicles was provoked. [50] [51] [52] This downregulation was followed by LHR upregulation.
The LHR expression peaked in the mid-luteal phase. This transient downregulation of LHR that was induced by the LH surge could be reproduced in the cell culture system and this effect of LH could be mimicked by 8-Br-cAMP stimulation. 53 In order to elucidate the precise mechanism underlying the downregulation of this receptor, the authors investigated the involvement of miRNAs in this phenomenon, which are small, non-coding RNAs of ~22 nucleotides that bind to the 3′-untranslated region of mRNAs. They are believed to negatively control post-transcriptional gene expression. 
| LUTEINIZATION
As previously mentioned, following the transient downregulation, LHR expression increased again and peaked in the mid-luteal phase. 21, 55 The mechanism that underlies LHR upregulation at this stage is not fully understood. In a recent report on the human luteinized granulosa cells, the addition of RU486, a progesterone receptor antagonist, inhibited the increase in LHR expression. 56 This result suggests that LHR expression in the luteal phase is, at least partly, controlled by progesterone that is secreted by the luteinized granulosa cells (Figure 3 ). 
| GONADOTROPIN RECEPTOR-DEFICIENT MOUSE MODELS
| Follicle-stimulating hormone receptor knockout mouse
The FSHR model (FORKO) mouse was established by a group of researchers 11 and has been characterized in detail. 57 These mice demonstrated phenotypes that were similar to those that were recognized in the FSHβ knockout mice. The FORKO males had limited fecundity. 58 Their testis was small in size and spermatogenesis was partially disturbed. 59 On the contrary, the FORKO females were infertile. They had small ovaries and a thin uterus. In the ovaries, the primordial, primary, and secondary follicles could be recognized with the normal number of granulosa and theca cells. However, folliculogenesis was blocked before the antral follicular stage. The expression of LHR was not affected by the knockout of FSHR and ERs also existed. 11 These results indicated that FSHR is essential for follicular development beyond the antral follicular stage.
| Luteinizing hormone receptor knockout mouse
Two research groups have generated LHR knockout (LuRKO) mouse models independently. 60, 61 Both the LuRKO males and females were infertile. In the LuRKO males, the testicular descent was blocked and the testis became diminished in size. In the testis, the number of Leydig cells was drastically decreased. The serum levels of gonadotropins were elevated and the testosterone level became lower.
Spermatogenesis was blocked at round spermatid stage. The LuRKO females had small ovaries, a thin uterus, and their vaginal opening 
| TRANSCRIPTIONAL CONTROLS OF THE GONADOTROPIN RECEPTORS
| Follicle-stimulating hormone receptor knockout mouse
The promoter activity of FSHR has been reported to be varied among species of primates. However, the sequence homology of the 5′ flanking region of the receptor has been highly conserved through evolution. 62 The information about the transcriptional control of FSHR and its expression and cause of organ specificity is still unknown. In the case of rats and humans, the 5′ flanking region of Upstream stimulating factors 1 and 2 (USF1/2) were reported to bind to this E-box sequence and to control FSHR transcription. The FSH stimulation caused a decrease in the USF1 expression, which led to a delay in the FSHR transcription. 63 Activin and transforming growth factor-β were reported to increase the transcription activity of the FSHR gene, but its mechanism is yet to be elucidated. For this activation, interaction with the E-box is presumed.
| Luteinizing hormone receptor
The promoter of the LHR gene contains binding sites of the specificity protein 1 (SP1), steroidogenic factor 1, and AP-2. Among these binding sites, the SP1 binding site was reported to be essential for the activation of the LHR transcription that was induced by cAMP. 64 One study reported that, for rat LHR expression, the 5′ flanking region from −171 to −137 bp is essential. It was identified that the early growth response gene-1 (Egr-1) was a transcription factor that binds to this promoter region and upregulates LHR expression. However, the expression of Egr-1 was observed in the luteinized granulosa cells, but not in the preovulatory granulosa cells. 65 Insulin-like growth factor-1, estradiol, and IL-6 enhanced LHR expression that was induced by FSH stimulation. Among these, only IL-6 could increase the promoter activity of LHR. 49 The IGF-1 and estradiol did not affect the promoter activity, but elongated the half-life of the LHR mRNA. 34, 38 In our previous report, TNF-α diminished the LHR promoter activity and FSH-induced LHR expression was decreased. In this phenomenon, nuclear factor-κB p65 was translocated to the nucleus and interacted with the promoter region of LHR. and IL-6 68,69 has been reported. Further analysis is desired in order to elucidate the mechanisms that are involved in these diseases and to improve ovulation induction therapy.
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